Robert Alexander Zimmermann (Robert Zimmermann, Robert A Zimmermann)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

ACS infectious diseases

ChemMedChem

ACS pharmacology & translational science

ACS medicinal chemistry letters

Johannes Gutenberg-Universität Mainz

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johannes Gutenberg-Universität Mainz Apr 01 2019

Germany

PhD student :: Institut für Pharmazeutische und Biomedizinische Wissenschaften

Publications

Natalie Fuchs, Robert Alexander Zimmermann, Marvin Schwickert, Annika Gunkel, Collin Zimmer, Mergim Meta, Kevin Schwickert, Jennifer Keiser, Cécile Haeberli, Werner Kiefer, Tanja Schirmeister
Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS infectious diseases 10 (5) (2024)
Natalie Fuchs, Robert Alexander Zimmermann, Marvin Schwickert, Annika Gunkel, Collin Zimmer, Mergim Meta, Kevin Schwickert, Jennifer Keiser, Cécile Haeberli, Werner Kiefer, Tanja Schirmeister
Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS infectious diseases 10 (5) (2024)
Natalie Fuchs, Robert Alexander Zimmermann, Marvin Schwickert, Annika Gunkel, Collin Zimmer, Mergim Meta, Kevin Schwickert, Jennifer Keiser, Cécile Haeberli, Werner Kiefer, Tanja Schirmeister
Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS infectious diseases (2024)
Natalie Fuchs, Robert Alexander Zimmermann, Marvin Schwickert, Annika Gunkel, Collin Zimmer, Mergim Meta, Kevin Schwickert, Jennifer Keiser, Cécile Haeberli, Werner Kiefer, Tanja Schirmeister
Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS infectious diseases 10 (5) (2024)
Robert Alexander Zimmermann, Tim R Fischer, Marvin Schwickert, Zarina Nidoieva, Tanja Schirmeister, Christian Kersten
Chemical Space Virtual Screening against Hard-to-Drug RNA Methyltransferases DNMT2 and NSUN6. International journal of molecular sciences 24 (7) (2023)
Marvin Schwickert, Robert Alexander Zimmermann, Tanja Habeck, Sabrina N Hoba, Zarina Nidoieva, Tim R Fischer, Martin M Stark, Christian Kersten, Frederik Lermyte, Mark Helm, Tanja Schirmeister
Covalent S -Adenosylhomocysteine-Based DNA Methyltransferase 2 Inhibitors with a New Type of Aryl Warhead. ACS medicinal chemistry letters 14 (6) (2023)
Robert Alexander Zimmermann, Marvin Schwickert, J Laurenz Meidner, Zarina Nidoieva, Mark Helm, Tanja Schirmeister
An Optimized Microscale Thermophoresis Method for High-Throughput Screening of DNA Methyltransferase 2 Ligands. ACS pharmacology & translational science 5 (11) (2022)
Armin Welker, Christian Kersten, Christin Müller, Ramakanth Madhugiri, Collin Zimmer, Patrick Müller, Robert Alexander Zimmermann, Stefan Hammerschmidt, Hannah Maus, John Ziebuhr, Christoph Sotriffer, Tanja Schirmeister
Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2. ChemMedChem 16 (2) (2020)

Robert Alexander Zimmermann.css-eqlu8i{font-size:small;padding-left:4px;} (Robert Zimmermann, Robert A Zimmermann)

Publication Activity (10 Years)

Top Topics

Top Venues

Robert Alexander Zimmermann (Robert Zimmermann, Robert A Zimmermann)